MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > More Demand - New Antibody Treatment requires Antibody Test!

<< Previous

Bullboard Posts

Next >>

Comment by Nathaniel13on Oct 04, 2020 8:43pm

97 Views

Post# 31665091

RE:RE:More Demand - New Antibody Treatment requires Antibody Test!

1st EUA then Webb manufacturing capacity. Per Webb: Revealcovid-19 Total Antibody Test, which fits in the palm of a hand, can be easily and inexpensively mass produced to meet the country’s urgent demand for a reliable antibody test.

Believe EUA will come in Oct, then partnerships (via Webb) for manufacturing in the US.

From the perspective of Science and Technology, I really believe MIR stands to make Canada's greatest impact in the fight against Covid-19 globally.

Inexpensive, fast and accurate; exactly what is needed to assess herd immunity and vaccine effectiveness on a large scale.

<< Previous

Bullboard Posts

Next >>

First Nations contributions attract investor interest